| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director | EVP & President, Protein
3 companies
Paul Sternlieb is President and CEO at EPAC and has filed Form 4s across 3 companies. Paul Sternlieb's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $23.4M at current prices.
The biggest single holding is EPAC (~$21.7M) as President and CEO. The EPAC filings lean toward selling, a net 2,700 shares.
Paul Sternlieb has 45 Form 4 filings on record from October 2017 to October 2026, across 3 companies: President and CEO at Enerpac Tool Group (EPAC), 2021–2026; Director at Kennametal (KMT), 2023–2026; EVP & President, Protein at JBT Marel (JBTM), 2017–2021.
The 68 reported transactions were 32 tax withholdings, 21 stock awards, 7 option exercises and 6 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $502K.
The largest open-market sale was 2,644 shares of JBTM at an average $145.00 on April 28, 2021, about $383K. Twelve months later JBTM was down 18%.